HKD 3.39
(-0.88%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | 297.31 Million HKD | 579.59% |
2022 | 43.75 Million HKD | 332.51% |
2021 | -18.81 Million HKD | 69.22% |
2020 | -61.13 Million HKD | -212.14% |
2019 | 54.51 Million HKD | -45.97% |
2018 | 100.9 Million HKD | 57.84% |
2017 | 63.92 Million HKD | 45.32% |
2016 | 43.99 Million HKD | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q2 | 21 Million HKD | 0.0% |
2023 Q4 | 209.79 Million HKD | 0.0% |
2023 Q2 | 87.52 Million HKD | 0.0% |
2023 FY | 297.31 Million HKD | 579.59% |
2022 Q4 | 21.27 Million HKD | 0.0% |
2022 FY | 43.75 Million HKD | 332.51% |
2022 Q2 | 22.47 Million HKD | 0.0% |
2021 FY | -18.81 Million HKD | 69.22% |
2021 Q2 | -10.97 Million HKD | 0.0% |
2021 Q4 | -7.84 Million HKD | 0.0% |
2020 Q2 | -48.35 Million HKD | 0.0% |
2020 Q4 | -12.77 Million HKD | 0.0% |
2020 FY | -61.13 Million HKD | -212.14% |
2019 Q4 | 9.99 Million HKD | 0.0% |
2019 Q2 | 44.52 Million HKD | 0.0% |
2019 FY | 54.51 Million HKD | -45.97% |
2018 Q4 | 13.62 Million HKD | 0.0% |
2018 FY | 100.9 Million HKD | 57.84% |
2018 Q2 | 25.22 Million HKD | 0.0% |
2018 Q1 | 25.22 Million HKD | 0.0% |
2017 Q1 | 15.98 Million HKD | 0.0% |
2017 Q2 | 15.98 Million HKD | 0.0% |
2017 Q4 | 25.22 Million HKD | 0.0% |
2017 FY | 63.92 Million HKD | 45.32% |
2016 FY | 43.99 Million HKD | 0.0% |
2016 Q4 | 15.98 Million HKD | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
China Healthwise Holdings Limited | -134.55 Million HKD | 320.96% |
Beijing Tong Ren Tang Chinese Medicine Company Limited | 540.39 Million HKD | 44.981% |